Home  |  About SITC  |   Twitter  |  LinkedIn  |  Sitemap

SITC 26th Annual Meeting

Annual Meeting Main PageAbstract Information  | Award Recipients  |  Early Career Scientists  |  Faculty
Presenter Slides & Schedule  |  Supporters  |  Photos & Video

November 4 - 6, 2011
Bethesda North Marriott Hotel & Conference Center
North Bethesda, MD

Program Schedule

Tuesday, November 1 - Wednesday, Nov 2

Summit on Cell Therapy for Cancer (Held at the Masur Auditorium, on the NIH Campus)
For more information, click here.
 

Thursday, November 3

8:00 am - 5:00 pm Workshop on Immunotherapy Combinations
For more information, click here.
8:00 am - 5:00 pm Primer on Tumor Immunology and Cancer Immunotherapy
For more information, please click here.
 

Friday, November 4  (26th Annual Meeting Begins)

7:50 am - 8:00 am President's Welcome
Thomas F. Gajewski, MD, PhD - University of Chicago
8:00 am - 8:45 am Richard V. Smalley, MD Memorial Lectureship
Vaccines That Target Dendritic Cells
Ralph M. Steinman, MD - The Rockefeller University
Speaker :  TBD
8:45 am - 11:30 am

 
Plenary Session:  Biology & Application of Dendritic Cells
Co-Chairs:    Nina Bhardwaj, MD, PhD - NYU Medical Center
                     Viggo Van Tendeloo, PhD - Antwerp University Hospital

Invited
Speakers:     Nina Bhardwaj, MD, PhD - NYU Medical Center
                     Robert Seder, MD - NIAID, NIH
                     Viggo Van Tendeloo, PhD - Antwerp University Hospital
11:30 am - 12:00 pm Plenary Session: To Be Announced
12:00 pm - 1:30 pm Lunch Break & Poster Viewing
1:30 pm - 3:00 pm


 
Concurrent Session I:  Immunology of Cancer Stem Cells and Epithelial-to-Mesenchymal
                                     Transition (EMT)

Co-Chairs:     Malcolm A.S. Moore, D.Phil - Memorial Sloan-Kettering Cancer Center
                      Jeffrey Schlom, PhD - National Cancer Institute, NIH
Invited
Speakers:     Malcolm A.S. Moore, D.Phil - Memorial Sloan-Kettering Cancer Center
                     Claudia M. Palena, PhD - National Cancer Institute, NIH
1:30 pm - 3:00 pm

 
Concurrent Session II: Uncoupling Negative Regulation in the Tumor Microenvironment
Co-Chairs:    Lieping Chen, MD, PhD - Yale University
                     Hassane M. Zarour, MD - University of Pittsburgh

Invited
Speakers:     Lieping Chen, MD, PhD - Yale University
                     Hassane M. Zarour, MD - University of Pittsburgh
3:15 pm - 5:15 pm


 
Plenary Session:  Genetically Engineered Receptors and Adoptive Cell Therapies
Co-Chairs:     Carl H. June, MD - University of Pennsylvania
                     
Dolores J. Schendel, PhD - Helmholz Zentrum Muenchen -
                                                                 German Research Center for Environmental Health

Invited
Speakers:     Laurence J.N. Cooper, MD, PhD - MD Anderson Cancer Center
                     Carl H. June, MD - University of Pennsylvania
                    
Dolores J. Schendel, PhD - Helmholz Zentrum Muenchen -
                                                                 German Research Center for Environmental Health
5:15 pm - 5:45 pm Plenary Session: Cancer Immunotherapy Trials Network (CITN) Update
Speaker:       Mary L. (Nora) Disis, MD - Co-Principal Investigator, Cancer Immunotherapy Trials
                                                            Network (CITN);
University of Washington
5:45 pm - 6:15 pm SITC Membership Business Meeting
Immediately Following
the Business Meeting
8:00 pm
Poster & Networking Reception
   

Saturday, November 5

8:00 am - 8:45 am Keynote Address: Innate Immune Recognition of Nucleic Acids
Katherine Fitzgerald, PhD - University of Massachusetts Medical School
8:45 am - 11:30 am

 
Plenary Session:  Characterization of Inflammatory Infiltrates in Human Cancers
Co-Chairs:     George Coukos, MD, PhD - University of Pennsylvania Medical Center
                      Wolf-Hervé Fridman, MD, PhD - INSERM
Invited
Speakers:      Vincenzo Bronte, MD - Verona University - Immunology Section
                      George Coukos, MD, PhD - University of Pennsylvania Medical Center
                      Wolf-Hervé Fridman, MD, PhD - INSERM
11:30 am - 12:00 pm Plenary Session: Late Breaking Abstracts
12:00 pm - 1:30 pm Lunch Break & Poster Viewing
1:30 pm - 3:00 pm
 
Concurrent Session I:  State of the Art Animal Models and Veterinary Applications for Cancer and Immunology
Co-Chairs:     Thomas Blankenstein, PhD - Max-Delbruck Center for Molecular Medicine
                      Jedd D. Wolchok, MD, PhD - Memorial Sloan-Kettering Cancer Center
Invited
Speakers:      Thomas Blankenstein, PhD - Max-Delbruck Center for Molecular Medicine
                       Taha Merghoub, PhD - Memorial Sloan-Kettering Cancer Center
1:30 pm - 3:00 pm
 
Concurrent Session II:  High Throughput Technologies for Immune Monitoring
Co-Chairs:     Philipp Beckhove, MD - German Cancer Research Center
                      Sacha Gnjatic, PhD - Ludwig Institute for Cancer Research
Invited
Speakers:     Philipp Beckhove, MD - German Cancer Research Center
                     Sacha Gnjatic, PhD - Ludwig Institute for Cancer Research
3:15 pm - 4:50 pm
 
Presidential Abstract Session
Chair:             Thomas F. Gajewski, MD, PhD - University of Chicago
4:50 pm - 5:20 pm Clinical Immunotherapy Guidelines Update
Speaker:         Howard L. Kaufman, MD - Rush University Medical Center   
5:20 pm - 5:35 pm National Cancer Institute, NIH Update
Speaker:         William Merritt, PhD - National Cancer Institute
5:35 pm - 5:50 pm FDA Update on Regulatory Issues Related to Cancer Immunotherapy
Speaker:         Raj K. Puri, MD, PhD - Food and Drug Administration, CBER
5:50 pm - 6:15 pm Award Presentations

6:15 pm - 8:00 pm

Presidential Reception with Poster Viewing

 
After 8:00 pm/
Presidential
Reception
Performance by the band The Checkpoints  

Sunday, November 6

8:00 am - 10:15 am

 
Plenary Session:  Prostate Cancer as a Learning Model
Co-Chairs:   Charles G. Drake, MD, PhD - Johns Hopkins University
                    James L. Gulley, MD, PhD - National Cancer Institute
Invited
Speakers:    Charles G. Drake, MD, PhD - Johns Hopkins University
                    James L. Gulley, MD, PhD - National Cancer Institute
                    Douglas G. McNeel, MD, PhD - University of Wisconsin
10:15 am Annual Meeting Adjourns
10:15 am - 12:00 pm Hot Topic Symposium: Targeting the Next Generation of Inhibitory Pathways
   



Society for Immunotherapy of Cancer
formerly the International Society for Biological Therapy of Cancer
555 East Wells Street, Suite 1100  |  Milwaukee, WI 53202-3823 USA
Tel: +1 414 271 2456  |  Fax: +1 414 276 3349  |  Email: info@sitcancer.org
About SITC  |  Meetings  |  Membership  |  Patient/Consumer Resources  |  Professional Resources  |  Support SITC
© 2012 Society for Immunotherapy of Cancer. All rights reserved.